The future of T-cell therapy—fully closed and automated manufacturing using novel capture particles

Smith, David; Peterson, Alaina; Zonderman, Jeff; Kevlahan, Sean; Hampson, Brian

doi:10.1016/j.jcyt.2017.03.029

Search citation statements

Order By: Relevance

Paper Sections

Select...

Looking Forward1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2017

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…CTP manufacturing equipment is rapidly evolving. Tremendous progress has been made toward fully closed automated systems [14,15]. These efforts are anticipated to enable more efficient and robust CTP manufacturing for both scale up and scale out purposes.…”

Section: Looking Forwardmentioning

confidence: 99%

Points to Consider for Cell Manufacturing Equipment and Components

Lin‐Gibson¹,

Hanrahan²,

Matosevic³

et al. 2017

Cell Gene Therapy Insights

View full text Add to dashboard Cite

Advances in manufacturing technologies, as well as early development and adoption of industry-wide standards will contribute to a vibrant industry for cell-based therapeutic products (CTP). A critical aspect is manufacturing equipment that can address specific and unique challenges associated with CTP manufacturing. The move towards fully closed and automated systems heightens the need for integrated and standardized strategies to ensure the manufacturing of CTPs with controlled safety and quality profiles. This paper summarizes key points to consider for cell manufacturing equipment and components. In addition to enabling common baseline understanding for equipment requirements, it is meant to stimulate broader discussions for developing best practices and standards for CTP manufacturing equipment.

show abstract

Section: Looking Forwardmentioning

confidence: 99%